Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial

BACKGROUND: Diabetes mellitus (DM) increases the risk of tuberculosis (TB) and will hamper global TB control due to the dramatic rise in type 2 DM in TB-endemic settings. In this trial, we will examine the efficacy and safety of TB preventive therapy against the development of TB disease in people w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ntinginya, Nyanda Elias, te Brake, Lindsey, Sabi, Issa, Chamba, Nyasatu, Kilonzo, Kajiru, Laizer, Sweetness, Andia-Biraro, Irene, Kibirige, Davis, Kyazze, Andrew Peter, Ninsiima, Sandra, Critchley, Julia A., Romeo, Renee, van de Maat, Josephine, Olomi, Willyhelmina, Mrema, Lucy, Magombola, David, Mwayula, Issakwisa Habakkuk, Sharples, Katrina, Hill, Philip C., van Crevel, Reinout
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186476/
https://www.ncbi.nlm.nih.gov/pubmed/35689272
http://dx.doi.org/10.1186/s13063-022-06296-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186476/
https://www.ncbi.nlm.nih.gov/pubmed/35689272
http://dx.doi.org/10.1186/s13063-022-06296-8

Ejemplares similares